filmov
tv
Drug discovery strategies: Focusing on synthetic compounds and natural products
Показать описание
Moderator: Kim Lewis, Northeastern University (USA)
Speakers:
Heike Brötz-Oesterhelt, University of Tübingen (Germany)
Scott J. Hecker, Qpex Biopharma (USA)
In this live webinar, the speakers gave the following presentations:
- Natural products in antibacterial drug discovery (Heike Brötz-Oesterhelt)
- Discovery of Xeruborbactam (QPX7728), an Ultra-broad-spectrum Boronic Acid Inhibitor of Serine and Metallo Beta-lactamases (Scott J. Hecker)
The presentations were followed by a Q&A session.
Speakers:
Heike Brötz-Oesterhelt, University of Tübingen (Germany)
Scott J. Hecker, Qpex Biopharma (USA)
In this live webinar, the speakers gave the following presentations:
- Natural products in antibacterial drug discovery (Heike Brötz-Oesterhelt)
- Discovery of Xeruborbactam (QPX7728), an Ultra-broad-spectrum Boronic Acid Inhibitor of Serine and Metallo Beta-lactamases (Scott J. Hecker)
The presentations were followed by a Q&A session.
1:24:56
Drug discovery strategies: Focusing on synthetic compounds and natural products
0:02:52
The Drug Discovery Process
0:19:11
From fragment-screening to fragment-growing - new strategies for drug discovery.
1:12:24
Cancer bioscience: too focused on drug discovery?
1:31:57
Progressing an antibacterial drug discovery project - an SME perspective
0:21:05
Use of waveRAPID® method in drug discovery strategies for membrane proteins | Dr. Nicolas Bocquet
0:53:24
Versatile Hit-Finding Strategies for Successful Drug Discovery Programs
0:01:04
Translational Integrated Drug Discovery
0:41:49
Management Strategies for CKD in Type 2 Diabetes
0:03:47
The Milwaukee Institute for Drug Discovery
0:43:40
Innovative Approaches to Biomarker Discovery in the Drug Development Process
0:03:05
Drawn to Science: Target identification in drug discovery
1:00:18
Biochemistry Focus ECR webinar series - Developments in Drug discovery
0:07:50
Drug Discovery and Development - Overview | New Drug Discovery Procedure | Science Land
1:30:41
Promise of artificial intelligence to antibacterial drug discovery
0:05:23
Artificial intelligence in life science and drug discovery - Paul Belcher
0:49:31
Genomic Advances in Drug Discovery & Development - Lon Cardon, Ph.D.
0:31:56
Virtual drug discovery - the challenges and opportunities for biotech
1:26:32
OPEN Stage Webinar: Drug Discovery & Development at NINDS
0:06:51
Novartis CEO discusses how AI will impact drug development
0:28:51
Patient-Focused Approaches to Drug Discovery in Neurodevelopmental Disorders
0:59:24
Emerging strategies in covalent inhibition
0:40:23
Prioritizing the Indications in Your Drug Discovery Portfolio
0:05:01
Nick Scott – R&D Productivity, New Approaches to Drug Discovery, Local Industrial Strategy
Комментарии